Table 5. Management of pre-eclampsia and eclampsia across pregnancy continuum.
| Medicine | Pregnancy | Labor and Delivery* | Postnatal* | |||
|---|---|---|---|---|---|---|
| EO-PE (n = 273) n (%) | LO-PE (n = 347) n (%) | EO-PE (n = 242) n (%) | LO-PE (n = 341) n (%) | EO-PE (n = 242) n (%) | LO-PE (n = 341) n (%) | |
| Antihypertensive medicines | ||||||
| Methyldopa (oral) | 259(94.9) | 289(83.3) | 230(95.0) | 287(84.2) | 230(95.0) | 295(86.5) |
| Nifedipine (oral) | 257(94.1) | 276(79.5) | 227(93.8) | 279(81.8) | 223(92.2) | 293(85.9) |
| Labetalol (oral) | 10(3.7) | 6(1.7) | 4(1.7) | 0.0 | 4(1.7) | 0.0 |
| Hydralazine (IV) | 69(25.3) | 33(9.5) | 34(14.1) | 18(5.3) | 21(8.7) | 15(4.4) |
| Anticonvulsants | ||||||
| MgSO4 | 164(60.1) | 178(51.3) | 99(40.9) | 133(39.0) | 49(20.3) | 89(26.1) |
| Diazepam | 3(1.1) | 0.0 | 0.0 | 2(0.6) | 1(0.4) | 2(0.6) |
| Phenytoin | 5(1.8) | 1(0.3) | 2(0.8) | 2(0.6) | 5(2.1) | 6(1.8) |
| Lasix (diuretic) | 10(3.7) | 3(0.9) | 6(2.5) | 4(1.2) | 13(5.4) | 4(1.2) |
| Prophylaxis | ||||||
| Junior Aspirin | 15(5.5) | 3(0.9) | 1(0.4) | 0.0 | 0.0 | 0.0 |
| Calcium | ||||||
IV, Intravenous.
*Analysis excludes 37 women discharged at ANC